352 related articles for article (PubMed ID: 35487285)
1. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic virotherapies for pediatric tumors.
Gross EG; Hamo MA; Estevez-Ordonez D; Laskay NM; Atchley TJ; Johnston JM; Markert JM
Expert Opin Biol Ther; 2023; 23(10):987-1003. PubMed ID: 37749907
[TBL] [Abstract][Full Text] [Related]
3. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.
Bernstock JD; Bag AK; Fiveash J; Kachurak K; Elsayed G; Chagoya G; Gessler F; Valdes PA; Madan-Swain A; Whitley R; Markert JM; Gillespie GY; Johnston JM; Friedman GK
Hum Gene Ther; 2020 Oct; 31(19-20):1132-1139. PubMed ID: 32657154
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success.
Hervás-Corpión I; Alonso MM
Int Rev Cell Mol Biol; 2023; 379():169-188. PubMed ID: 37541723
[TBL] [Abstract][Full Text] [Related]
5. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas.
Estevez-Ordonez D; Chagoya G; Salehani A; Atchley TJ; Laskay NMB; Parr MS; Elsayed GA; Mahavadi AK; Rahm SP; Friedman GK; Markert JM
Neurosurg Clin N Am; 2021 Apr; 32(2):265-281. PubMed ID: 33781507
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.
Kazemi Shariat Panahi H; Dehhaghi M; Lam SS; Peng W; Aghbashlo M; Tabatabaei M; Guillemin GJ
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1122-1142. PubMed ID: 34004331
[TBL] [Abstract][Full Text] [Related]
7. The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.
Bernstock JD; Hoffman SE; Chen JA; Gupta S; Kappel AD; Smith TR; Chiocca EA
Viruses; 2021 Jun; 13(6):. PubMed ID: 34204248
[TBL] [Abstract][Full Text] [Related]
8. Promises of oncolytic viral therapy for adult and children with brain glioma.
Patiño-García A; Alonso MM; Gállego Pérez-Larraya J
Curr Opin Oncol; 2023 Nov; 35(6):529-535. PubMed ID: 37820087
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
Totsch SK; Schlappi C; Kang KD; Ishizuka AS; Lynn GM; Fox B; Beierle EA; Whitley RJ; Markert JM; Gillespie GY; Bernstock JD; Friedman GK
Oncogene; 2019 Aug; 38(34):6159-6171. PubMed ID: 31289361
[TBL] [Abstract][Full Text] [Related]
10. Immunovirotherapy for Pediatric Solid Tumors: A Promising Treatment That is Becoming a Reality.
de la Nava D; Selvi KM; Alonso MM
Front Immunol; 2022; 13():866892. PubMed ID: 35493490
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
Friedman GK; Johnston JM; Bag AK; Bernstock JD; Li R; Aban I; Kachurak K; Nan L; Kang KD; Totsch S; Schlappi C; Martin AM; Pastakia D; McNall-Knapp R; Farouk Sait S; Khakoo Y; Karajannis MA; Woodling K; Palmer JD; Osorio DS; Leonard J; Abdelbaki MS; Madan-Swain A; Atkinson TP; Whitley RJ; Fiveash JB; Markert JM; Gillespie GY
N Engl J Med; 2021 Apr; 384(17):1613-1622. PubMed ID: 33838625
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Virotherapy for the Treatment of Malignant Glioma.
Foreman PM; Friedman GK; Cassady KA; Markert JM
Neurotherapeutics; 2017 Apr; 14(2):333-344. PubMed ID: 28265902
[TBL] [Abstract][Full Text] [Related]
13. Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.
Waters AM; Johnston JM; Reddy AT; Fiveash J; Madan-Swain A; Kachurak K; Bag AK; Gillespie GY; Markert JM; Friedman GK
Hum Gene Ther Clin Dev; 2017 Mar; 28(1):7-16. PubMed ID: 28319448
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic virus therapy for malignant gliomas: entering the new era.
Fudaba H; Wakimoto H
Expert Opin Biol Ther; 2023 Mar; 23(3):269-282. PubMed ID: 36809883
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular immunovirotherapy; a translational step forward.
Bernstock JD; Blitz S; Kang KD; Friedman GK
Oncotarget; 2023 Jan; 14():40-43. PubMed ID: 36634220
[TBL] [Abstract][Full Text] [Related]
16. [Oncolytic virus therapy for malignant brain tumors].
Ino Y; Todo T
Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
Friedman GK; Bernstock JD; Chen D; Nan L; Moore BP; Kelly VM; Youngblood SL; Langford CP; Han X; Ring EK; Beierle EA; Gillespie GY; Markert JM
Sci Rep; 2018 Sep; 8(1):13930. PubMed ID: 30224769
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors.
Bernstock JD; Wright Z; Bag AK; Gessler F; Gillespie GY; Markert JM; Friedman GK; Johnston JM
World Neurosurg; 2019 Feb; 122():e1592-e1598. PubMed ID: 30481622
[TBL] [Abstract][Full Text] [Related]
19. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.
Pol JG; Lévesque S; Workenhe ST; Gujar S; Le Boeuf F; Clements DR; Fahrner JE; Fend L; Bell JC; Mossman KL; Fucikova J; Spisek R; Zitvogel L; Kroemer G; Galluzzi L
Oncoimmunology; 2018; 7(12):e1503032. PubMed ID: 30524901
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic Virotherapy in Glioma Tumors.
Rius-Rocabert S; García-Romero N; García A; Ayuso-Sacido A; Nistal-Villan E
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]